中文 / English

Address: No. 35, Simiao Road, Daxing Biomedical Industrial Base, Zhongguancun Science Park, Daxing District, Beijing
 Copyright: Beijing Minhai Biological Technology Co., Ltd.    京ICP备10007676号-1   Powered by Beijing    Beijing Public Security No. 110115000037 Internet Drug Information Service Qualification Certificate (Beijing) Non-operating 20150173           


Administrative Office: 010-59613600
Supplier consultation: 010-59613585
Recruitment: 010-59613547
Marketing: 010-59613639
Medical support: 010-57864983


400 :4001899806


The World Health Organization and the US CDC visited Minhai

The World Health Organization and the US CDC visited Minhai

Release time:
Page view

  June 21, 2019, Roland Walter Sutter, Coordinator, Office of Polio Eradication, World Health Organization, Carolyn Sein, Technical Officer, Office of Polio Eradication, World Health Organization, Mark Steven Oberste, Head of Polio Lab, US Centers for Disease Control, World Health Organization China Senior officials Zuo Shuyan and his entourage visited Minhai. General manager Zheng Haifa and other senior executives extended a warm welcome to the World Health Organization and his delegation.

During the meeting, the visiting experts had a detailed understanding of the company's current sIPV project progress, including the project's overall schedule, process optimization progress, clinical progress, plant and facility progress, PQ and GAPIII progress, etc. Afterwards, the visiting experts visited the sIPV production workshop and gave a high evaluation of the production capacity and biosafety design of the production workshop.



  The visiting experts affirmed the progress of Minhai Biological's sIPV project, and encouraged Minhai to speed up the clinical, registration and WHO pre-certification progress of sIPV, to be listed in China as soon as possible, and to UNICEF after passing the WHO pre-certification And other institutions.